Tech Company Financing Transactions
Embera NeuroTherapeutics Funding Round
On 10/4/2019, Embera NeuroTherapeutics raised $6.1 million in investment from private investors.
Transaction Overview
Company Name
Announced On
10/4/2019
Transaction Type
Venture Equity
Amount
$6,128,235
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 70 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
365 Boston Post Rd. 210
Sudbury, MA 01776
USA
Sudbury, MA 01776
USA
Phone
Website
Email Address
Not Recorded
Overview
Embera is developing a patent-pending drug combination, EMB-001, that addresses significant unmet needs in smoking cessation and cocaine dependence.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Linke
Vice President
Julie Straub
VP - Operations
Gary Connor
VP - Regulatory Affairs
Ann Robbins
Browse more venture capital transactions:
Prev: 10/4/2019: Osaro venture capital transaction
Next: 10/4/2019: X1 venture capital transaction
Share this article
News on VC Transactions
We do our best to document all VC transactions involving tech companies. VC transactions reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs